Solid technical action. Uptrend intact. Watching with keen interest the coming a-b-c completion and next break.Fundamentals intriguing at this stage.IMBOOC
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling